About Merge Bio Therapeutics
Merge Bio Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2025 in Delaware. It has reported $4,999,998 raised in one offering on Form D since September 2025. Its chief executive is Wesley Wong.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 26, 2025 | Sep 17, 2025 | $4,999,998of $14.9M target | 1 | $4.9M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Merge Bio Therapeutics's Form D filed Sep 17, 2025.
ML
Mark Lipstein
Promoter
SL
Steve Liapis
Director
CH
Clinton Hansen
Executive officer and promoter
EQ
Elias Quijano
Director
WW
Wesley Wong
Chief Executive Officer and director
DY
Darren Yang
Promoter